CEO: Jonas Ekstrand
Description: The AlzeCure Foundation was formed late 2012 in collaboration with a group of former senior AstraZeneca scientists, the Swedish Alzheimer Foundation and Prof. Bengt Winblad at the Karolinska Institutet. The aim of AlzeCure is to develop new methods and therapeutics to better diagnose and treat neurodegenerative diseases, primarily Alzheimer’s Disease. The team has several ongoing projects directed towards both Medicinal Technology and Drug Discovery. AlzeCure is a flexible, professional and innovative unit that collaborates with leading academic groups, clinics and innovative biotechnology, pharmaceutical and diagnostic companies to bring value to both patients and society.